e-ISSN: Pending
Negative / Null Result ReportOpen accessTherapeutics. Pharmacology

The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics

Jiagen Wen; Meizi Zeng; Zhaoqian Liu; Honghao Zhou; Heng Xu; Min Huang; Wei Zhang · 2019 · Journal of Pharmacological Sciences

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Metformin is the most widely used drug among type 2 diabetes mellitus patients. However, drug interaction on metformin will influence its glucose-lowering effect or increase its side effect of lactic acidosis. In this study, a randomized, two-stage, crossover study was conducted to unveil the potential drug interaction between metformin and the anti-hypertension drug, telmisartan. Totally, 16 healthy Chinese male volunteers were enrolled. Blood samples from various time-points after drug adminstration were analyzed for metformin quantification. Oral glucose tolerance test (OGTT) was conducted

Abstract by Jiagen Wen; Meizi Zeng; Zhaoqian Liu; Honghao Zhou; Heng Xu; Min Huang; Wei Zhang, Journal of Pharmacological Sciences (2019) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1016/j.jphs.2018.11.007